國家衛生研究院 NHRI:Item 3990099045/15384
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 908650      線上人數 : 1050
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/15384


    題名: Meta-analysis of CYP2C19 and CYP2D6 metabolic activity on antidepressant response from 13 clinical studies
    作者: Li, D;Pain, O;Fabbri, C;Wong, WLE;Lo, CWH;Ripke, S;Cattaneo, A;Souery, D;Dernovsek, MZ;Henigsberg, N;Hauser, J;Lewis, G;Mors, O;Perroud, N;Rietschel, M;Uher, R;Maier, W;Aitchison, KJ;Baune, BT;Biernacka, JM;Bondolfi, G;Domschke, K;Kato, M;Liu, YL;Serretti, A;Tsai, SJ;Weinshilboum, R;McIntosh, AM;Lewis, CM
    貢獻者: Center for Neuropsychiatric Research
    摘要: Cytochrome P450 enzymes including CYP2C19 and CYP2D6 are important for antidepressant metabolism and polymorphisms of these genes have been determined to predict metabolite levels. Nonetheless, more evidence is needed to understand the impact of genetic variations on antidepressant response. In this study, individual data from 13 clinical studies of European and East Asian ancestry populations were collected. The antidepressant response was clinically assessed as remission and percentage improvement. Imputed genotype was used to translate genetic polymorphisms to four metabolic phenotypes (poor, intermediate, normal, and ultrarapid) of CYP2C19 and CYP2D6. The association of CYP2C19 and CYP2D6 metabolic phenotypes with treatment response was examined using normal metabolizers as the reference. Among 5843 depression patients, a higher remission rate was found in CYP2C19 poor metabolizers compared to normal metabolizers at nominal significance (OR = 1.46, 95% CI [1.03, 2.06], p = 0.033) but did not survive after multiple testing correction. No metabolic phenotype was associated with percentage improvement from baseline. After stratifying by antidepressants primarily metabolized by CYP2C19 and CYP2D6, no association was found between metabolic phenotypes and antidepressant response. Metabolic phenotypes showed differences in frequency, but not effect, between European and East Asian studies. In conclusion, metabolic phenotypes imputed from genetic variants were not associated with antidepressant response. CYP2C19 poor metabolizers could potentially contribute to antidepressant efficacy with more evidence needed. Information including side effects, antidepressant dosage, as well as population from different ancestries could be involved to fully capture the influence of metabolic phenotypes and improve the power of effect assessment.
    日期: 2023-06-28
    關聯: medRxiv. 2023 Jun 28;Article in Press.
    Link to: http://dx.doi.org/10.1101/2023.06.26.23291890
    顯示於類別:[劉玉麗] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    PUB37425775.pdf541KbAdobe PDF79檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋